The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Cathepsin G Activates Protease-activated Receptor-4 in Human Platelets
Open accessAbstract
Of the four known protease-activated receptors (PARs), PAR1 and PAR4 are expressed by human platelets and mediate thrombin signaling. Whether these receptors are redundant, interact, or play at least partially distinct roles is unknown. It is possible that PAR1 and/or PAR4 might confer responsiveness to proteases other than thrombin. The neutrophil granule protease, cathepsin G, is known to cause platelet secretion and aggregation. We now report that this action of cathepsin G is mediated by PAR4. Cathepsin G triggered calcium mobilization in PAR4-transfected fibroblasts, PAR4-expressing Xenopus oocytes, and washed human platelets. An antibody raised against the PAR4 thrombin cleavage site blocked platelet activation by cathepsin G but not other agonists. Desensitization with a PAR4 activating peptide had a similar effect. By contrast, inhibition of PAR1 function had no effect on platelet responses to cathepsin G. When neutrophils were present, the neutrophil agonist fMet-Leu-Phe triggered calcium signaling in Fura-2-loaded platelets. Strikingly, this neutrophil-dependent platelet activation was blocked by the PAR4 antibody. These data show that PAR4 mediates platelet responses to cathepsin G and support the hypothesis that cathepsin G might mediate neutrophil-platelet interactions at sites of vascular injury or inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vu, T.-K. H., Hung, D. T., Wheaton, V. I., & Coughlin, S. R. (1991) · Cell · doi:10.1016/0092-8674(91)90261-v · Cited by 2,970
Self-citationInflammation. Basic principles and clinical correlates
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90156-x · Cited by 2,393
A dual thrombin receptor system for platelet activation
Kahn, M. L., Zheng, Y.-W., Huang, W., Bigornia, V., Zeng, D., Moff, S., Farese, R. V., Tam, C., & Coughlin, S. R. (1998) · Nature · doi:10.1038/29325 · Cited by 979
Self-citationMolecular cloning of a potential proteinase activated receptor.
Nystedt, S., Emilsson, K., Wahlestedt, C., & Sundelin, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9208 · Cited by 886
Protease-activated receptor 3 is a second thrombin receptor in humans
Ishihara, H., Connolly, A. J., Zeng, D., Kahn, M. L., Wu Zheng, Y., Timmons, C., Tram, T., & Coughlin, S. R. (1997) · Nature · doi:10.1038/386502a0 · Cited by 865
Self-citationProtease-activated receptors 1 and 4 mediate activation of human platelets by thrombin
Kahn, M. L., Nakanishi-Matsui, M., Shapiro, M. J., Ishihara, H., & Coughlin, S. R. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6042 · Cited by 841
Self-citationCloning and characterization of human protease-activated receptor 4
Xu, W.-F., Andersen, H., Whitmore, T. E., Presnell, S. R., Yee, D. P., Ching, A., Gilbert, T., Davie, E. W., & Foster, D. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6642 · Cited by 817
Kinetics of the reversible inhibition of enzyme-catalysed reactions by tight-binding inhibitors
Morrison, J. F. (1969) · Biochimica et Biophysica Acta (BBA) - Enzymology · doi:10.1016/0005-2744(69)90420-3 · Cited by 814
[17] The kinetics of reversible tight-binding inhibition
Williams, J. W., & Morrison, J. F. (1979) · Methods in Enzymology · doi:10.1016/0076-6879(79)63019-7 · Cited by 693
Susceptibility to Infection and Altered Hematopoiesis in Mice Deficient in Both P- and E-Selectins
Frenette, P. S., Mayadas, T. N., Rayburn, H., Hynes, R. O., & Wagner, D. D. (1996) · Cell · doi:10.1016/s0092-8674(00)81032-6 · Cited by 509
Hattori, R., Hamilton, K. K., Fugate, R. D., McEver, R. P., & Sims, P. J. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83104-0 · Cited by 451
The cell biology of leukocyte-mediated proteolysis
Owen, C. A., & Campbell, E. J. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.65.2.137 · Cited by 439
Owen, C. A., Campbell, M. A., Sannes, P. L., Boukedes, S. S., & Campbell, E. J. (1995) · The Journal of cell biology · doi:10.1083/jcb.131.3.775 · Cited by 381
Leukocyte rolling in vivo is mediated by P-selectin glycoprotein ligand- 1
Norman, K., Moore, K., McEver, R., & Ley, K. (1995) · Blood · doi:10.1182/blood.v86.12.4417.bloodjournal86124417 · Cited by 250
Defects in hemostasis in P-selectin-deficient mice
Subramaniam, M., Frenette, P., Saffaripour, S., Johnson, R., Hynes, R., & Wagner, D. (1996) · Blood · doi:10.1182/blood.v87.4.1238.bloodjournal8741238 · Cited by 197
Chen, J., Ishii, M., Wang, L., Ishii, K., & Coughlin, S. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33970-4 · Cited by 194
Self-citationMolino, M., Blanchard, N., Belmonte, E., Tarver, A. P., Abrams, C. S., Hoxie, J. A., Cerletti, C., & Brass, L. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.19.11168 · Cited by 150
Hung, D. T., Vu, T.-K. H., Nelken, N. A., & Coughlin, S. R. (1992) · The Journal of Cell Biology · doi:10.1083/jcb.116.3.827 · Cited by 148
Self-citationDevelopment of Potent Thrombin Receptor Antagonist Peptides
Bernatowicz, M. S., Klimas, C. E., Hartl, K. S., Peluso, M., Allegretto, N. J., & Seiler, S. M. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960455s · Cited by 144
Trejo, J., Connolly, A. J., & Coughlin, S. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.35.21536 · Cited by 128
Self-citationHuman neutrophil cathepsin G is a potent platelet activator
LaRosa, C. A., Rohrer, M. J., Benoit, S., Rodino, L. J., Barnard, M. R., & Michelson, A. D. (1994) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(94)70106-7 · Cited by 82
Si‐Tahar, M., Pidard, D., Balloy, V., Moniatte, M., Kieffer, N., DORSSELAER, A. V., & Chignard, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.17.11636 · Cited by 79
Brozna, J. (1990) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-1002685 · Cited by 77
Owen, C. A., Campbell, M. A., Boukedes, S. S., & Campbell, E. J. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.12.5803 · Cited by 74
Evangelista, V., Piccardoni, P., Jg, W., de Gaetano, G., & Cerletti, C. (1993) · Blood · doi:10.1182/blood.v81.11.2947.2947 · Cited by 66
Platelet Activation by Polymorphonuclear Leukocytes: Role of Cathepsin G and P-Selectin
Cerletti, C., Evangelista, V., Molino, M., & de Gaetano, G. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1642680 · Cited by 64
Augmented Inflammatory Responses and Altered Wound Healing in Cathepsin G–Deficient Mice
Abbott, R. E., Corral, C. J., MacIvor, D. M., Lin, X., Ley, T. J., & Mustoe, T. A. (1998) · Archives of Surgery · doi:10.1001/archsurg.133.9.1002 · Cited by 48
Molino, M., Lallo, M. D., de Gaetano, G., & Cerletti, C. (1992) · Biochemical Journal · doi:10.1042/bj2880741 · Cited by 33
Engineering bidentate macromolecular inhibitors for trypsin and urokinase-type plasminogen activator
Yang, S. Q., & Craik, C. S. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1749 · Cited by 20
Self-citation
Cited by
Neutrophil extracellular traps in immunity and disease
Papayannopoulos, V. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.105 · Cited by 3,397
Thrombin signalling and protease-activated receptors
Coughlin, S. R. (2000) · Nature · doi:10.1038/35025229 · Cited by 2,482
Self-citationProteinase-activated Receptors
(2006) · Encyclopedic Reference of Molecular Pharmacology · doi:10.1007/3-540-29832-0_1335 · Cited by 1,137
Protease-Activated Receptors: Contribution to Physiology and Disease
OSSOVSKAYA, V. S., & BUNNETT, N. W. (2004) · Physiological Reviews · doi:10.1152/physrev.00028.2003 · Cited by 1,078
Protease‐activated receptors in hemostasis, thrombosis and vascular biology
COUGHLIN, S. R. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01377.x · Cited by 1,035
Self-citation
Metadata
- Authors
- Sambrano, G. R., Huang, W., Faruqi, T., Mahrus, S., Craik, C., & Coughlin, S. R.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-03
- Volume
- 275
- Issue
- 10
- Pages
- 6819-6823
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2076409217
- Cited by
- 345
- References
- 29
- FWCI
- 9.77
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.